Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Accumulated Expenses (2023 - 2025)

Jin Medical International (ZJYL) has disclosed Accumulated Expenses for 3 consecutive years, with $41613.0 as the latest value for Q3 2025.

  • Quarterly Accumulated Expenses fell 88.72% to $41613.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $41613.0 through Sep 2025, down 88.72% year-over-year, with the annual reading at $41613.0 for FY2025, 88.72% down from the prior year.
  • Accumulated Expenses hit $41613.0 in Q3 2025 for Jin Medical International, down from $368885.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $368885.0 in Q3 2024 to a low of $41613.0 in Q3 2025.
  • Historically, Accumulated Expenses has averaged $242999.3 across 3 years, with a median of $318500.0 in 2023.
  • Biggest five-year swings in Accumulated Expenses: rose 15.82% in 2024 and later tumbled 88.72% in 2025.
  • Year by year, Accumulated Expenses stood at $318500.0 in 2023, then grew by 15.82% to $368885.0 in 2024, then crashed by 88.72% to $41613.0 in 2025.
  • Business Quant data shows Accumulated Expenses for ZJYL at $41613.0 in Q3 2025, $368885.0 in Q3 2024, and $318500.0 in Q3 2023.